Metro Healthcare Indonesia Tbk. vs Merck Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp426 (market cap 14.16T, 119.3K 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 8.1× Merck Tbk.'s market cap, and Metro Healthcare Indonesia Tbk. is more actively traded (119.3K versus 29.1K). Which is the better fit depends on your goals.
| CARE | MERK | |
|---|---|---|
Market Cap | 14.16T | 1.75T |
Volume | 119.3K | 29.1K |
Lot | 1.19K | 291 |
Turnover | 50.51M | 113.37M |
Average Price | 423.41 | 3,895.98 |
Value | 50.51M | 113.37M |
Indicative Equilibrium Price | 426 | 3,890 |
Indicative Equilibrium Volume | 50 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →